Doximity (DOCS) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
15 Jul, 2026Executive summary
Annual meeting scheduled for August 27, 2026, at 9:00 a.m. Pacific Time, with virtual attendance available.
Shareholders are encouraged to review proxy materials and vote by August 26, 2026.
Voting matters and shareholder proposals
Election of two Class II Directors, Kevin Spain and Timothy Cabral, to serve until 2029.
Ratification of Deloitte & Touche LLP as independent auditor for the year ending March 31, 2027.
Advisory vote to approve executive compensation for the fiscal year ended March 31, 2026.
Proxies may vote on other matters arising at the meeting or any adjournments.
Board of directors and corporate governance
Board recommends voting in favor of all proposals, including director nominees and auditor ratification.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Doximity
- Proxy covers director elections, auditor ratification, and executive pay, with strong governance and ESG focus.DOCS
Proxy filing15 Jul 2026 - 20% revenue growth, record margins, and strong AI-driven engagement set up for cautious FY26.DOCS
Q4 20259 Jul 2026 - Q3 revenue up 25% with margin expansion, record engagement, and ongoing share repurchases.DOCS
Q3 20258 Jul 2026 - Record free cash flow, strong AI adoption, and 13% revenue growth set up modest FY27 outlook.DOCS
Q4 202620 May 2026 - Delivers AI-powered workflow tools to 85%+ of U.S. physicians, achieving 22% revenue CAGR.DOCS
Investor presentation13 May 2026 - Revenue up 10% to $185.1M, strong margins, AI acquisition, and $500M buyback authorized.DOCS
Q3 202616 Apr 2026 - AI-powered platform with 85% physician reach, rapid revenue growth, and strong market penetration.DOCS
Investor presentation25 Feb 2026 - Revenue up 17% to $126.7M, profits and margins rose, and FY25 guidance was raised.DOCS
Q1 20251 Feb 2026 - Q2 revenue up 20% to $137M, net income up 44%, and margins hit records on strong platform growth.DOCS
Q2 202515 Jan 2026